Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.rmed.2006.04.009
Title: A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma
Authors: Ferguson, A.C.
Van Bever, H.P. 
Teper, A.M.
Lasytsya, O.
Goldfrad, C.H.
Whitehead, P.J.
Keywords: Asthma
Budesonide
Children
Fluticasone propionate
Growth
Issue Date: Jan-2007
Source: Ferguson, A.C., Van Bever, H.P., Teper, A.M., Lasytsya, O., Goldfrad, C.H., Whitehead, P.J. (2007-01). A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Respiratory Medicine 101 (1) : 118-129. ScholarBank@NUS Repository. https://doi.org/10.1016/j.rmed.2006.04.009
Abstract: There have been no previous large, well-designed direct comparisons of the effects of fluticasone propionate (FP) and budesonide (BUD) on growth in children. This randomised, double-blind study compared the effects on growth of FP and BUD in children aged 6-9 years with persistent asthma. Following a 6-month run-in period (without inhaled corticosteroids), patients with normal growth velocity were randomised to 12 months' treatment with FP 100 μg bd (n = 114) or BUD 200 μg bd (n = 119). Growth velocity was determined by stadiometric height measurement. Lung function, asthma symptoms and use of relief medication were also assessed. Annualised mean growth velocity during run-in was comparable in the two groups (FP: 5.9 cm/yr; BUD: 6.0 cm/yr). During the treatment period, adjusted mean growth velocity was significantly higher in the FP than the BUD group (5.5 cm/yr vs 4.6 cm/yr; P < 0.001). Asthma control improved similarly in both treatment groups. Bone mineral density and overnight urinary cortisol:creatinine ratios were similar in the two groups. Drug-related adverse events were reported among 3% of FP-treated children, compared with 2% for BUD. In conclusion, this study demonstrates that FP for childhood asthma has significantly less impact on childhood growth velocity than a therapeutically equivalent dose of BUD. © 2006 Elsevier Ltd. All rights reserved.
Source Title: Respiratory Medicine
URI: http://scholarbank.nus.edu.sg/handle/10635/129807
ISSN: 09546111
DOI: 10.1016/j.rmed.2006.04.009
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

24
checked on Mar 7, 2018

WEB OF SCIENCETM
Citations

21
checked on Mar 7, 2018

Page view(s)

11
checked on Feb 25, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.